EuroSurg Collaborative, ItSURG, STARSurg Collaborative (2020) Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery. British Journal of Surgery, 107 (2). e161-e169. ISSN 0007-1323
Full text not available from this repository.Abstract
Background: Ileus is common after elective colorectal surgery, and is associated with increased adverse events and prolonged hospital stay. The aim was to assess the role of non-steroidal anti-inflammatory drugs (NSAIDs) for reducing ileus after surgery. Methods: A prospective multicentre cohort study was delivered by an international, student- and trainee-led collaborative group. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The primary outcome was time to gastrointestinal recovery, measured using a composite measure of bowel function and tolerance to oral intake. The impact of NSAIDs was explored using Cox regression analyses, including the results of a centre-specific survey of compliance to enhanced recovery principles. Secondary safety outcomes included anastomotic leak rate and acute kidney injury. Results: A total of 4164 patients were included, with a median age of 68 (i.q.r. 57–75) years (54·9 per cent men). Some 1153 (27·7 per cent) received NSAIDs on postoperative days 1–3, of whom 1061 (92·0 per cent) received non-selective cyclo-oxygenase inhibitors. After adjustment for baseline differences, the mean time to gastrointestinal recovery did not differ significantly between patients who received NSAIDs and those who did not (4·6 versus 4·8 days; hazard ratio 1·04, 95 per cent c.i. 0·96 to 1·12; P = 0·360). There were no significant differences in anastomotic leak rate (5·4 versus 4·6 per cent; P = 0·349) or acute kidney injury (14·3 versus 13·8 per cent; P = 0·666) between the groups. Significantly fewer patients receiving NSAIDs required strong opioid analgesia (35·3 versus 56·7 per cent; P < 0·001). Conclusion: NSAIDs did not reduce the time for gastrointestinal recovery after colorectal surgery, but they were safe and associated with reduced postoperative opioid requirement.
Item Type: | Article |
---|---|
Additional Information: | Acknowledgements: The authors are grateful to the European Society of Coloproctology (ESCP) Executive for providing facilities to host collaborator meetings in Berlin (September 2017) and Nice (September 2018); the ESCP Cohort Studies and Audits Committee for their review of the study protocol; and the Dukes Club (UK), the Portuguese Surgical Research Collaborative, the Young Group of the Italian Society of Colorectal Surgery, the Italian Surgical Research Group, the Australasian Students' Surgical Association, and the Clinical Trials Network of Australia and New Zealand for assistance with study dissemination. They thank the Birmingham Surgical Trials Consortium at the University of Birmingham (UK) for support with online data capture, and the Yorkshire Surgical Research Collaborative (UK) for access to unpublished data. Disclosure: The authors declare no conflict of interest. |
Uncontrolled Keywords: | medicine(all) ,/dk/atira/pure/subjectarea/asjc/2700 |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
Related URLs: | |
Depositing User: | LivePure Connector |
Date Deposited: | 07 Sep 2022 09:30 |
Last Modified: | 23 Jul 2024 01:52 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/87775 |
DOI: | 10.1002/bjs.11326 |
Actions (login required)
![]() |
View Item |